Effects of peptidoglycan on proliferation and cell cycle of human bone marrow-derived mesenchymal stem cells.
- Author:
Ya-Nan SU
1
;
Hai BAI
;
Cun-Bang WANG
;
Xiao-Hui MA
;
Jian-Feng OU
;
Qiang ZHAO
;
Xiao-Xia HE
;
Wei-Wei SONG
Author Information
1. Center for Blood Diseases of Chinese PLA, Lanzhou Military Area Lanzhou General Hosipital, Lanzhou 730050, Gansu Province, China.
- Publication Type:Journal Article
- MeSH:
Bone Marrow Cells;
cytology;
Cell Cycle;
drug effects;
Cell Proliferation;
drug effects;
Cells, Cultured;
Flow Cytometry;
Humans;
Mesenchymal Stromal Cells;
cytology;
Peptidoglycan;
pharmacology;
Toll-Like Receptor 2
- From:
Journal of Experimental Hematology
2010;18(4):986-990
- CountryChina
- Language:Chinese
-
Abstract:
This study was aimed to explore the effects of peptidoglycan (PGN) on proliferation and cell cycle of human bone marrow mesenchymal stem cells (MSCs). MSCs were isolated from human bone marrow by density gradient centrifugation. The purity of MSCs with the spindle fibroblastic morphology was identified by microphotography and the phenotypes were detected by flow cytometry (FCM). MSCs incubated with different doses of PGN (1, 10, 20 μg/ml) were used as test groups, and those incubated without PGN were regarded as control group. The isolated and cultured MSCs were inoculated into 96-well plates according to a certain concentration. Cell cycle was measured by flow cytometry after incubated with PGN for 72 hours. The results showed that the cell proliferation index was significantly increased in dose and time dependent manners after MSCs was incubated with PGN. Its effects on the proliferation of MSCs were highest in 10 μg/ml group. Compared with the control group, PGN could significantly decrease proportion of MSCs in G₀/G₁ phase and increase them in S and G₂/M phases (p < 0.05). It is concluded that PGN can promote more MSCs to enter the DNA synthesis phase and proliferate many much MSCs in dose and time dependent manners.
